financetom
Business
financetom
/
Business
/
IES Holdings Insider Sold Shares Worth $23,918,700, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IES Holdings Insider Sold Shares Worth $23,918,700, According to a Recent SEC Filing
Sep 17, 2024 12:44 AM

03:27 AM EDT, 09/17/2024 (MT Newswires) -- Jeffrey L Gendell, 10% Owner, Director, Chief Executive Officer, on September 12, 2024, sold 150,000 shares in IES Holdings ( IESC ) for $23,918,700. Following the Form 4 filing with the SEC, Gendell has control over a total of 10,934,845 shares of the company, with 10,934,845 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048268/000104826824000114/xslF345X05/wk-form4_1726527820.xml

Price: 161.00, Change: +0.75, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bitcoin miner LM Funding misses Q3 revenue estimates
Bitcoin miner LM Funding misses Q3 revenue estimates
Nov 14, 2025
Overview * LM Funding Q3 revenue grows 73.5% yr/yr but misses analyst expectations * Net loss for Q3 was $3.7 mln, adjusted EBITDA missed analyst expectations * Company acquired 11 MW Bitcoin mining facility in Mississippi, boosting production Outlook * Company anticipates Oklahoma site expansion to energize in December 2025 * LM Funding expects improved Bitcoin production and efficiency from...
Exclusive-Teamshares to list in US via $746 million T. Rowe Price-backed SPAC deal
Exclusive-Teamshares to list in US via $746 million T. Rowe Price-backed SPAC deal
Nov 14, 2025
(Reuters) -Teamshares, a buyer of small- to medium-sized enterprises, said on Friday it would go public in the U.S. through a $746 million blank-check deal with Live Oak Acquisition Corp backed by accounts advised by investment giant T. Rowe Price ( TROW ). Special purpose acquisition deals have made a comeback on Wall Street in 2025 after years of muted...
Ionis Pharmaceuticals Says Dawnzera Recommended for Approval in EU for Hereditary Angioedema
Ionis Pharmaceuticals Says Dawnzera Recommended for Approval in EU for Hereditary Angioedema
Nov 14, 2025
07:36 AM EST, 11/14/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Friday that it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for Dawnzera to prevent recurrent attacks of hereditary angioedema in patients aged 12 years and older. The company said the opinion was based on results from phase...
Top Premarket Gainers
Top Premarket Gainers
Nov 14, 2025
07:37 AM EST, 11/14/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) shares were more than 100% higher pre-bell Friday after the company agreed to be acquired by Merck (MRK) in a deal worth about $9.20 billion. Invivyd ( IVVD ) stock was up 55% following a muted session. Binah Capital ( BCG ) shares were 38% higher, a day...
Copyright 2023-2026 - www.financetom.com All Rights Reserved